Roche's Valium gets label update; trontinemab Alzheimer's trials continue as active, not recruitingSep 25Weekly roundup, 6 itemsChugai PharmaceuticaldiazepamUpdated
Polaryx Therapeutics names Will Charlton chief medical officer ahead of Phase 2 trialSep 1PeoplePolaryx Therapeutics, Inc.
Sign inSign in